4.7 Article

Persistence of Excess Mortality Following Individual Nonhip Fractures: A Relative Survival Analysis

期刊

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
卷 103, 期 9, 页码 3205-3214

出版社

ENDOCRINE SOC
DOI: 10.1210/jc.2017-02656

关键词

-

资金

  1. National Health Medical Research Council Australia [1070187, 1008219, 1073430]
  2. Osteoporosis Australia-Amgen grant
  3. Bupa Health Foundation
  4. Mrs. Gibson and Ernest Heine Family Foundation
  5. Amgen
  6. Merck Sharp Dohme
  7. Sanofi-Aventis
  8. Servier
  9. Novartis
  10. National Health and Medical Research Council of Australia [1070187, 1073430] Funding Source: NHMRC

向作者/读者索取更多资源

Context: Little is known about long-term excess mortality following fragility nonhip fractures. Objective: The study aimed to determine which fracture was associated with excess mortality and for how long the postfracture excess mortality persisted. Design, Setting, and Patients: This nationwide registry-based follow-up study included all individuals in Denmark aged 50+ years who first experienced fragility fractures in 2001 and were followed up for up to 10 years for their mortality risk. Main Outcome Measure: The contribution of fracture to mortality at precise postfracture time intervals was examined using relative survival analysis, accounting for time-related mortality changes in the background population. Results: There were 21,123 women (aged 72 +/- 13 years) and 9481 men (aged 67 +/- 12 years) with an incident fragility fracture in 2001, followed by 10,668 and 4745 deaths, respectively. Excess mortality was observed following all proximal and lower leg fractures. The majority of deaths occurred within the first year after fracture, and thereafter excess mortality gradually declined. Hip fractures were associated with the highest excess mortality (33% and 20% at 1 year after fracture in men and women, respectively). One-year excess mortality after fracture of a femur or pelvis was 20% to 25%; vertebrae, 10%; humerus, rib, or clavicle, 5% to 10%; and lower leg, 3%. A significant although smaller excess mortality was still observed until 10 years for hip fractures and -5 years after femur, other proximal, and lower leg fractures. Conclusion: This study highlights the important contribution of a wide variety of fragility fractures to long-term excess mortality and thus the potential for benefit from early intervention.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据